PL EN


Preferences help
enabled [disable] Abstract
Number of results
2011 | 119 | 1 | 81-83
Article title

Iron in Alzheimer's and Control Hippocampi - Mössbauer, Atomic Absorption and ELISA Studies

Content
Title variants
Languages of publication
EN
Abstracts
EN
Alzheimer disease is a neurodegenerative process of unknown mechanism taking place in a part of the brain - hippocampus. Oxidative stress and the role of iron in it is one of the suggested mechanisms of cells death. In this study several methods were used to assess iron and iron binding compounds in human hippocampus tissues. Mössbauer spectroscopy was used for identification of the iron binding compound and determination of total iron concentration in 12 control and one Alzheimer disease sample of hippocampus. Mössbauer parameters obtained for all samples suggest that most of the iron is ferritin-like iron. The average concentration of iron determined by Mössbauer spectroscopy in control hippocampus was 45±10 ng/mg wet tissue. The average concentration of iron in 10 Alzheimer disease samples determined by atomic absorption was 66±13 ng/mg wet tissue. The concentration of H and L chains of ferritin in 20 control and 10 AD hippocampi was assessed with enzyme-linked immuno-absorbent assay. The concentration of H and L ferritin was higher in Alzheimer disease compared to control (19.36±1.51 vs. 5.84±0.55 ng/μg protein for H, and 1.39±0.25 vs. 0.55±0.10 for L). This 3-fold increase of the concentration of ferritin is accompanied by a small increase of the total iron concentration.
Keywords
EN
Publisher

Year
Volume
119
Issue
1
Pages
81-83
Physical description
Dates
published
2011-01
Contributors
  • Faculty of Physics, Warsaw University of Technology, Warsaw, Poland
author
  • Racah Institute of Physics, Hebrew University of Jerusalem, Jerusalem, Israel
author
  • Faculty of Physics, Warsaw University of Technology, Warsaw, Poland
  • Department of Neurology, Medical University in Warsaw, Warsaw, Poland
author
  • Biochemistry Laboratory, Brodno Voivodship Hospital, Warsaw, Poland
author
  • Faculty of Pharmacy, Medical University of Warsaw, Warsaw, Poland
author
  • Department of Neurology, Mayo Clinic, Jacksonville, USA
author
  • Department of Neuroscience, Mayo Clinic, Jacksonville, USA
author
  • Faculty of Pharmacy, Medical University of Lodz, Łódź, Poland
author
  • Department of Neurology, Medical University in Warsaw, Warsaw, Poland
References
  • 1. P. Arosio, R. Ingrassia, P. Cavadini, Biochim. Biophys. Acta 1790, 589 (2009)
  • 2. J. Gałązka-Friedman, E.R. Bauminge, D. Koziorowski, A. Friedman, Biochim. Biophys. Acta 1688, 130 (2004)
  • 3. D. Koziorowski, A. Friedman, P. Arosio, P. Santambrogio, D. Dziewulska, Parkinsonism Relat. Disord. 13, 214 (2007)
  • 4. A. Wypijewska, J. Gałązka-Friedman, E.R. Bauminger, Z.K. Wszolek, K.J. Schweitzer, D.W. Dickson, A. Jaklewicz, D. Elbaum, A. Friedman, Parkinsonism Relat. Disord. 16, 329 (2010)
  • 5. J. Gałązka-Friedman, E.R. Bauminger, A. Friedman, M. Barcikowska, D. Hechel, I. Nowik, Mov. Disord. 11, 8 (1996)
  • 6. M.A. Deibel, W.D. Ehmann, W.R. Markesbery, J. Neurol. Sci. 143, 137 (1996)
  • 7. J. Gałązka-Friedman, E.R. Bauminger, K. Szlachta, K. Schweitzer, Z.K. Wszolek, D. Dickson, A. Friedman, Acta Phys. Pol. A 115, 431 (2009)
Document Type
Publication order reference
Identifiers
YADDA identifier
bwmeta1.element.bwnjournal-article-appv119n123kz
JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.